Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 12.539\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) C/C(=N/Nc1nc(C)cc(C)n1)c1ccc(Br)cc1
b.) Oc1ccc(/C=C/c2ccc3cccc(O)c3n2)cc1Br
c.) COc1ccc(C2Nc3ccccc3NC3=C2C(=O)CC(C)(C)C3)cc1O
d.) O=C1[C@H]2[C@H]3[C@H](O)[C@H](O)C/C(=N\OC[C@@H](O)COCc4ccco4)[C@@H]3CC[C@H]2C(=O)N1c1ccc(F)cc1F
e.) COc1ccc(-c2nnc(SCC(=O)NC3CCCC3)n2C)cc1
Answer: e. COc1ccc(-c2nnc(SCC(=O)NC3CCCC3)n2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-c2nnc(SCC(=O)NC3CCCC3)n2C)cc1
COc1ccc(-c2nnc(SCC(=O)NC3CCCC3)n2C)cc1
N-cyclopentyl-2-[[5-(4-methoxyphenyl)-4-methyl-1,2,4-triazol-3-yl]sulfanyl]acetamide